routine switching is not recommended because these alternatives are used much less frequently than ramipril, and a sudden rise in demand could put pressure on their supplies too.
The latest warning follows a shortage of 1.25mg ramipril capsules reported earlier this year.
A serious shortage protocol remains in place for the capsules, meaning that pharmacists can at times restrict supplies to one month’s worth.
The protocol also allows pharmacists to provide a reduced quantity compared with the number of days originally prescribed.
Pharmacy leaders have raised concerns about the